Andrew Schiff

Andrew Schiff

Président chez MONTE ROSA THERAPEUTICS, INC.

Fortune : 5 363 $ au 30/04/2024

58 ans
Health Technology
Health Services
Consumer Services

Profil

Andrew N.
Schiff
is currently the Chairman at Visiting Nurse Service of New York.
He is also the Non-Executive Chairman at Monte Rosa Therapeutics, Inc. since 2023.
In addition, he serves as an Independent Director at Aclaris Therapeutics, Inc. and as a Director at Planet Biopharmaceuticals, Inc., Henry Street Settlement, Inc., Planet Technologies, Inc., Dren Bio, Inc., and Aisling Capital LLC, where he has been the Managing Partner since 2000.
Previously, Dr. Schiff held positions as a Director at Bioenvision, Inc., Gilead Colorado, Inc., Barrier Therapeutics, Inc., CardioKine, Inc., and SkinMedica, Inc. He was also an Independent Director at Agile Therapeutics, Inc. from 2014 to 2016.
Additionally, he served as a Director at ArgiNOx Pharmaceuticals, Inc., PowerVision, Inc., Adams Respiratory Therapeutics, Inc., Sirion Holdings, Inc., Dynova Laboratories, Inc., Colorescience Corp., ZELTIQ Aesthetics, Inc., TransEnterix, Inc., Miramar Technologies, Inc., ARMGO Pharma, Inc., Cempra, Inc., Quintiles Transnational Holdings, Inc., Sirion Therapeutics, Inc., F2G Ltd., Zavante Therapeutics, Inc., Harmony Biosciences Holdings, Inc., and IQVIA RDS Asia, Inc.Dr. Schiff's education includes an undergraduate degree from Brown University, an MBA from The Trustees of Columbia University in The City of New York, and a doctorate from Weill Cornell Medical College.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
16/04/2024 4 507 ( 0,01% ) 5 363 $ 30/04/2024
31/03/2024 0 ( -.--% ) - $ 30/04/2024

Postes actifs de Andrew Schiff

SociétésPosteDébut
ACLARIS THERAPEUTICS, INC. Directeur/Membre du Conseil 09/08/2017
MONTE ROSA THERAPEUTICS, INC. Président 01/06/2023
Directeur/Membre du Conseil -
Président -
Directeur/Membre du Conseil -
Private Equity Investor 01/01/2000
Directeur/Membre du Conseil -
Directeur/Membre du Conseil 09/07/2010
Tous les postes actifs de Andrew Schiff

Anciens postes connus de Andrew Schiff

SociétésPosteFin
ZELTIQ AESTHETICS INC Directeur/Membre du Conseil 28/04/2017
░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -
░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -
Voir l'expérience en détail de Andrew Schiff

Formation de Andrew Schiff

Brown University Undergraduate Degree
The Trustees of Columbia University in The City of New York Masters Business Admin
Weill Cornell Medical College Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Andrew Schiff

Relations

100 +

Relations au 1er degré

35

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées4
AGILE THERAPEUTICS, INC.

Health Technology

ACLARIS THERAPEUTICS, INC.

Health Technology

HARMONY BIOSCIENCES HOLDINGS, INC.

Health Technology

MONTE ROSA THERAPEUTICS, INC.

Health Technology

Entreprise privées28

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

Distribution Services

Health Technology

Electronic Technology

Health Technology

Finance

Health Technology

Retail Trade

Retail Trade

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Services

Health Technology

Health Services

Health Technology

Health Technology

Commercial Services

Technology Services

Health Technology

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Andrew Schiff
-40% Offre à Durée Limitée : Nos abonnements vous guident vers les meilleurs investissements de demain.
PROFITEZ-EN MAINTENANT